Prophylactic hyperthermic intraperitoneal chemotherapy for gastric cancer: Current evidence, persistent uncertainties, and future perspectives

doi:10.3748/wjg.118763

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 32, Issue 30

This Article

(3)

(0)

(20)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Opinion Review

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Gastroenterol. Aug 14, 2026; 32(30): 118763
Published online Aug 14, 2026. doi: 10.3748/wjg.118763

Open in New Tab Full Size Figure Download Figure

Figure 1 Prophylactic hyperthermic intraperitoneal chemotherapy in gastric cancer: A schematic overview. This figure summarizes the core components of prophylactic hyperthermic intraperitoneal chemotherapy in gastric cancer, including conflicting survival evidence, favorable safety profile, patient selection, treatment protocol standardization, and emerging technologies and synergistic combinations beyond conventional hyperthermic intraperitoneal chemotherapy. HIPEC: Hyperthermic intraperitoneal chemotherapy.

Citation: Cheng ZW, Liang YZ, Wei M, Yan ZB, Sun GR, Cui XH, Yu WB. Prophylactic hyperthermic intraperitoneal chemotherapy for gastric cancer: Current evidence, persistent uncertainties, and future perspectives. World J Gastroenterol 2026; 32(30): 118763
URL: https://www.wjgnet.com/1007-9327/full/v32/i30/118763.htm
DOI: https://dx.doi.org/10.3748/wjg.118763

Cheng ZW, Liang YZ, Wei M, Yan ZB, Sun GR, Cui XH, Yu WB. Prophylactic hyperthermic intraperitoneal chemotherapy for gastric cancer: Current evidence, persistent uncertainties, and future perspectives. World J Gastroenterol 2026; 32(30): 118763 [DOI: 10.3748/wjg.118763]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.